X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DR. DATSONS LABS UNICHEM LAB/
DR. DATSONS LABS
 
P/E (TTM) x 30.5 -10.9 - View Chart
P/BV x 3.2 0.2 1,979.9% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 UNICHEM LAB   DR. DATSONS LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
DR. DATSONS LABS
Mar-14
UNICHEM LAB/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs334126 265.9%   
Low Rs17431 563.1%   
Sales per share (Unadj.) Rs146.9133.0 110.5%  
Earnings per share (Unadj.) Rs11.90.2 7,844.7%  
Cash flow per share (Unadj.) Rs16.26.6 245.0%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.1128.8 81.6%  
Shares outstanding (eoy) m90.8431.66 286.9%   
Bonus/Rights/Conversions ESOPFCCB-  
Price / Sales ratio x1.70.6 293.8%   
Avg P/E ratio x21.4516.1 4.1%  
P/CF ratio (eoy) x15.711.8 132.5%  
Price / Book Value ratio x2.40.6 397.7%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0732,477 931.4%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,55856 4,567.8%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,3464,211 317.0%  
Other income Rs m19279 243.8%   
Total revenues Rs m13,5384,289 315.6%   
Gross profit Rs m1,639569 288.3%  
Depreciation Rs m390204 190.8%   
Interest Rs m29430 6.7%   
Profit before tax Rs m1,41213 11,118.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m-4-2 205.6%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2936 4,798.4%   
Profit after tax Rs m1,0805 22,508.3%  
Gross profit margin %12.313.5 90.9%  
Effective tax rate %20.748.0 43.2%   
Net profit margin %8.10.1 7,101.3%  
BALANCE SHEET DATA
Current assets Rs m5,9796,852 87.3%   
Current liabilities Rs m2,4326,711 36.2%   
Net working cap to sales %26.63.3 793.8%  
Current ratio x2.51.0 240.8%  
Inventory Days Days63161 39.2%  
Debtors Days Days60318 19.0%  
Net fixed assets Rs m6,4033,673 174.3%   
Share capital Rs m182317 57.4%   
"Free" reserves Rs m9,2933,761 247.1%   
Net worth Rs m9,5484,078 234.2%   
Long term debt Rs m2301,671 13.8%   
Total assets Rs m12,84312,633 101.7%  
Interest coverage x50.01.0 4,859.7%   
Debt to equity ratio x00.4 5.9%  
Sales to assets ratio x1.00.3 311.8%   
Return on assets %8.63.4 250.8%  
Return on equity %11.30.1 9,611.8%  
Return on capital %14.37.7 186.8%  
Exports to sales %29.222.9 127.6%   
Imports to sales %6.314.3 44.4%   
Exports (fob) Rs m3,900964 404.5%   
Imports (cif) Rs m847602 140.7%   
Fx inflow Rs m4,356964 451.9%   
Fx outflow Rs m1,162607 191.5%   
Net fx Rs m3,194357 895.0%   
CASH FLOW
From Operations Rs m1,1191,345 83.2%  
From Investments Rs m-853-2,256 37.8%  
From Financial Activity Rs m-334-1,200 27.9%  
Net Cashflow Rs m-68-2,111 3.2%  

Share Holding

Indian Promoters % 50.1 4.5 1,106.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 1.4 222.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 94.1 33.7%  
Shareholders   20,176 20,807 97.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   STRIDES SHASUN LTD  AJANTA PHARMA  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Strong US Markets; SBI, Tata Steel & Other Top Cues to Sway the Markets Today(Pre-Open)

After opening the day in green, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

What Should Mutual Fund Investors Do After LTCG Tax Norms(Outside View)

Feb 6, 2018

PersonalFN explain what investors should after LTCG tax norms.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Feb 16, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS